Risk-based Computer System Validation: Reduce Costs and Avoid 483s - 2 Day Online Course (August 6-7, 2025)
The 'Risk-based Computer System Validation; Reduce Costs and Avoid 483s (ONLINE EVENT: August 6-7, 2025)' has been added to ResearchAndMarkets.com's offering.
This highly interactive two-day course uses real life examples and explores proven techniques for reducing costs, usually by two-thirds, associated with implementing, and maintaining computer systems in regulated environments.
Course Features
Learning Objectives
Who Should Attend:
Agenda:
DAY 1
DAY 2
For more information about this course visit https://www.researchandmarkets.com/r/d75gk1
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250519811437/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: NETWORKS OTHER TECHNOLOGY TECHNOLOGY TRAINING EDUCATION
SOURCE: Research and Markets
Copyright Business Wire 2025.
PUB: 05/19/2025 07:39 AM/DISC: 05/19/2025 07:38 AM
http://www.businesswire.com/news/home/20250519811437/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
HSBC Raises Novo Nordisk (NVO) Price Target on Oral Semaglutide Market Share Boost
Novo Nordisk A/S (NYSE:NVO) is one of the best falling stocks to buy now. On August 7, HSBC maintained a 'Hold' rating on Novo Nordisk and lifted the price target to 355 Danish Krone (DKK) from DKK340. HSBC increased the price target because it raised its estimates for the market share of oral semaglutide. Semaglutide is a pill that helps people with type 2 diabetes or obesity manage their condition. Novo Nordisk sells oral semaglutide for diabetes under the brand name Rybelsus. Pixabay/Public Domain HSBC projects that peak sales for the drug could exceed DKK15 billion ($2.34 billion) after 2034. The bank kept the 'Hold' rating on the stock due to 'ongoing concerns about market size' and 'overhang compounders.' The analysts identified a potential 'upside' for the stock if there is a recovery in Wegovy prescriptions in the U.S. Novo Nordisk A/S (NYSE:NVO) is a Danish global healthcare company. It develops and manufactures pharmaceutical products for chronic diseases, with a primary focus on diabetes, obesity, and rare blood and endocrine disorders. The company's portfolio includes GLP-1 therapies, such as Ozempic and Wegovy, as well as insulin and growth hormone treatments. While we acknowledge the potential of NVO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 12 Best Copper Stocks to Buy According to Hedge Funds and 10 Best EV Penny Stocks to Buy According to Hedge Funds. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
The Verge
3 minutes ago
- The Verge
Another Pixel 10 leak points to wireless Qi2 charging
We're just one week away from Google's Pixel 10 launch event, but the steady stream of leaks shows no sign of stopping. Now, new leaked images shared by Dutch outlet NieuweMobiel show what looks like Google's rumored 'Pixelsnap' cases with a ring in the center, hinting at support for the Qi2 wireless charging standard. Bringing Qi2 magnetic charging to the Pixel 10 would be a pretty big deal. Among Android phones, only the HMD Skyline comes with the built-in magnets to fully support Qi2 magnetic charging, while 'Qi2 Ready' phones like Samsung's newest foldables rely on magnetic cases to make them Qi2-compatible. This latest leak aligns with another leak we saw last month, which showed the Pixel 10 what appears to be a wireless charging puck. As shown by NieuweMobiel, the new Pixel 10 cases could come in blue, black, green, and light blue, while the Pixel 10 Pro and Pro XL could have gray, green, and white options. Posts from this author will be added to your daily email digest and your homepage feed. See All by Emma Roth Posts from this topic will be added to your daily email digest and your homepage feed. See All Google Posts from this topic will be added to your daily email digest and your homepage feed. See All Google Pixel Posts from this topic will be added to your daily email digest and your homepage feed. See All Mobile Posts from this topic will be added to your daily email digest and your homepage feed. See All News Posts from this topic will be added to your daily email digest and your homepage feed. See All Tech
Yahoo
31 minutes ago
- Yahoo
Wall Street's Wild Rally: Why No One Cares About Tariffs Anymore
Investors are in full-on risk modeand they're not waiting around to see how the Trump tariffs play out. From small caps to crypto, riskier corners of the market are lighting up as bets on a Federal Reserve rate cut heat up. The S&P 500 (SPY) is up nearly 30% from its April lows, with Tesla (NASDAQ:TSLA) and other megacap techs carrying most of the load. According to Deutsche Bank, just a handful of tech giants were responsible for 90% of the index's Q2 earnings growth. The Russell 2000 is climbing for the fourth straight month, emerging-market stocks are catching bids, and even speculative European bank bonds are finding buyers. The fear? Gone. Volatility measures like the VIX and MOVE indexes are plumbing their lowest levels in months. Traders are now pricing in a nearly 90% chance the Fed cuts rates in September, with some even betting on a 50-basis-point move. Treasury Secretary Scott Bessent added fuel to that fire, saying rates should probably be 150 to 175 basis points lower. The market has latched onto that narrative. Even currency volatility has dropped to its lowest in a year. All the while, the economic backdrop remains soft: labor market data isn't running hot, inflation came in as expected, and for now, that's enough. The mood is surprisingly bullishit's almost like what tariffs, who cares?' said Neil Birrell, CIO at Premier Miton. That detachment from reality? It's workingat least for now. But not everyone's ready to join the parade. It's very expensive right now to be bearish, said UBS O'Connor's Bernard Ahkong, who still sees plenty of risks lurking in the background. Bloomberg's Mark Cudmore warned that rising long-end yields or another Trump curveball could snap the rally. Still, Wall Street strategistssome of whom had slashed targets back in Aprilare now raising their outlooks. Citigroup's Scott Chronert even bumped up his year-end S&P 500 target, betting that potential tax cuts could outweigh tariff impacts. For now, the market's not trading fearit's trading FOMO. This article first appeared on GuruFocus. Sign in to access your portfolio
